Background Restenosis after balloon angioplasty of coronary arteries is thought to be a proliferative response of the arterial wall to injury. Recently, it has been suggested that geometric remodeling of the arterial wall, rather than intimal fibromuscular hyperplasia, may be the major pathophysiological mechanism underlying restenosis. In this study, we evaluated the relative contribution of a geometric decrease in arterial size versus neointimal growth to luminal narrowing associated with restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.
Background Restenosis after balloon angioplasty of coronary arteries is thought to be a proliferative response of the arterial wall to injury. Recently, it has been suggested that geometric remodeling of the arterial wall, rather than intimal fibromuscular hyperplasia, may be the major pathophysiological mechanism underlying restenosis. In this study, we evaluated the relative contribution of a geometric decrease in arterial size versus neointimal growth to luminal narrowing associated with restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.
Methods and Results Focal femoral atherosclerosis was induced by endothelial desiccation injury followed by a 2% cholesterol diet. After 1 month on the high cholesterol diet, the animals were subjected to one of four strategies: (1) balloon angioplasty, (2) balloon angioplasty followed by treatment with the factor Xa inhibitor antistasin, (3) combined laser and balloon angioplasty, or (4) no angioplasty. Animals were killed 2 hours or 28 days after angioplasty, and excised femoral artery segments were prepared for histomorphometric analysis. Angiography was performed serially before and immediately after angioplasty and before the animals were killed. An initial postprocedural gain in luminal diameter at sites of angioplasty was followed by a significant reduction in diameter by angiography and a significant increase in luminal crosssectional area narrowing by plaque by histomorphometry 28 days after angioplasty compared to adjacent nonangioplastied segments of the same arteries, to nonangioplastied control arteries, or to angioplastied segments of animals treated with the factor Xa inhibitor antistasin. By contrast, the overall arterial size (cross-sectional area bounded by the external elastic lamina) at sites of restenosis was not significantly different from adjacent nonangioplastied segments in the majority of arteries excised at 28 days, and the mean overall arterial size at sites of restenosis was not significantly different from corresponding segments of nonangioplastied control arteries or from angioplastied segments of animals treated with antistasin. In the minority of angioplastied arteries in which the arterial size did change, most got larger.
Conclusions Geometric remodeling resulting in a decrease in overall cross-sectional arterial size does not appear to be the principal pathogenetic mechanism for restenosis after balloon angioplasty with or without laser in this experimental model. (Circulation. 1994; 90:3001-3008.) Key Words * balloon * angioplasty * restenosis i remodeling igration and proliferation of activated medial smooth muscle cells, with elaboration by these cells of abundant extracellular matrix, have been considered to be the principal pathophysiological mechanisms of restenosis after angioplasty.1-3 Discrepancies between success in inhibiting restenosis in experimental animals using agents that attenuate smooth muscle cell proliferation and the disappointing results of several clinical trials have raised doubts concerning the mechanisms of restenosis in humans. Moreover, reports of marked antiproliferative effects of agents in one animal model have not always been confirmed in other animal models. A recent immunocytochemical study of human coronary atherectomy specimens from primary and restenotic lesions using the proliferating cell nuclear antigen (PCNA) has suggested that proliferation occurs infrequently and at low levels in both types of lesions.4 Using serial, quantitative intravascular ultrasound studies in humans, Mintz and coworkers5 suggested that the predominant mechanism responsible for the late reduction in luminal area (restenosis) is a geometric remodeling of the vascular wall, that is, a decrease in arterial size rather than increased luminal cross-sectional area narrowing by intimal fibromuscular hyperplasia. Support for this hypothesis was offered in another study using the atherosclerotic rabbit model, in which it was suggested that the restenotic process is mediated by both chronic vasoconstriction and cell proliferation. 6 The present correlative angiographic and histomorphometric study, using the atherosclerotic rabbit femo- ral artery model, focuses on the question of whether the decrease in absolute cross-sectional area of the lumen after balloon angioplasty, with or without laser, is associated with an increase in luminal narrowing by plaque or is due to a reduction in overall size of the "restenotic" vessel segment (Fig 1) .
Methods

Study Design
This analysis was performed on arterial segments from 48 adult male New Zealand White rabbits: 27 rabbits formed part of a previous study of the nature and extent of the arterial injury after balloon angioplasty with or without laser in the atherosclerotic rabbit (hereafter referred to as "study A"),7 and 21 rabbits formed part of a study, using the same model, of the effects of the specific factor Xa inhibitor antistasin (hereafter referred to as "study B").8 Animals were anesthetized by intramuscular injection of ketamine (50 mg/kg) and xylazine (5 mg/kg). Atherosclerosis was induced bilaterally in 1to 2-cm femoral artery segments by a combination of air desiccation endothelial injury followed by a 2% cholesterol, 6% peanut oil diet for 1 month as described previously.7-1" The animals were assigned to the following groups: from study A (excised 2 hours or 28 days after angioplasty), balloon angioplasty only (number of arteries, n=12 and 8, respectively), laser angioplasty followed by balloon angioplasty (n=4 and 11), and no balloon or laser (n=7 and 6); from study B (excised 28 days after angioplasty), balloon only (n=13) and balloon with antistasin (n=19).
Before angioplasty, a SF Berman angiographic balloon catheter (Arrow International) was inserted into the right common carotid artery and advanced to two vertebral segments above the iliac bifurcation. A single bolus of heparin (150 to 250 U/kg, heparin sodium injection [source, porcine intestinal mucosa], 1000 USP U/mL, Solopak Laboratories) was administered, and a baseline angiogram was obtained. The angiographic catheter was replaced by a 2.5 -mm balloon dilation catheter (Advanced Cardiovascular Systems, Inc), which was advanced across the femoral stenosis under fluoroscopic guidance. Three 60-second, 10-atm inflations were performed at 60-second intervals using a hand inflater as described previously.7-10 The mean balloon-to-vessel ratio for the arteries of this study (ratio of balloon diameter to the average of normal arterial diameters proximal and distal to the stenosis) was 1.3±0.2 mm. This catheter system, therefore, provided for slight "oversizing," resulting in deep arterial injury, as summarized below (see "Results") and reported in detail previously.7-10 After a postangioplasty angiogram, the carotid artery was ligated and the wound sutured. Final angiography was performed through the contralateral carotid artery immediately before the rabbits were killed (2 hours or 28 days).
Laser angioplasty (n=15 with laser before balloon angioplasty) was performed in antegrade fashion using a 1.5-mm Laser Prime catheter coupled to a Thallium/Holmium/Chromium:YAG infra-red laser (Eclipse 2100 Cardiovascular Laser System, Eclipse Surgical Technologies) with the technical specifications and pulse sequence reported previously.7 Angiography was performed as described above.
Recombinant antistasin was prepared as described previously. 12 Antistasin was administered intravenously as a 0.5 mg/kg bolus followed by infusion of 0.25 mg/kg per hour for 1 hour after angioplasty and 0.125 mg/kg per hour for a second hour as described previously. 8 The rabbits were fed standard chow after the intervention and were housed in accordance with Animal Welfare Act specifications. All surgical procedures conformed to the guidelines detailed in the "Position of the American Heart Association on Research Animal Use."
Analysis of Angiograms
Measurements were performed by blinded analysis using a computer-assisted system described previously.913 Minimum luminal diameters were measured at the site of focal femoral artery stenosis and of segments proximal and distal to the stenosis. The site examined for restenosis was the point corresponding to the maximal diameter reduction on the preangioplasty angiogram even if this was not the most severely narrowed site at subsequent time points. Angiographic data on initial gain and final loss (luminal diameter) for each artery excised at 28 days (study A and B) were correlated with the histopathological data on cross-sectional area narrowing.
Specimen Preparation for Histomorphometry
With the angiographic catheter positioned above the aortoiliac bifurcation, animals were administered an overdose of Nembutal (sodium pentobarbital), and the distal arterial tree was pressure perfused with 10% buffered formaldehyde (100 mL for 15 minutes, 100 mm Hg, room temperature). Segments (4 to 5 cm) of the femoral arteries were excised bilaterally and preserved in 10% formaldehyde for light microscopy. Arterial segments were cut in cross section at 1-to 2-mm intervals, dehydrated in ethanol and xylene, and embedded in paraffin. Serial (5 -,m) sections were stained by hematoxylin-eosin and by the Movat pentachrome method.14 Histopathological analysis was performed by observers blinded to treatment group and time of death. Four segments were identified from each excised femoral artery: the most narrowed by plaque (MNP) and the one with the smallest luminal cross-sectional area (SL) from the angioplasty site, and the least narrowed by plaque (LNP) and the one with the largest luminal cross-sectional area (LL) from adjacent nonangioplastied segments. Each segment was evaluated by computerized histomorphometry for vessel size, lumen size, and cross-sectional area narrowing by plaque.
Arterial size was determined by computerized linear measurement of the perimeter of the external elastic lamina (EEL), and calculation of the area assuming the EEL described a perfect circle (A=C2/47r). This method was chosen over the direct measurement of the area to ensure homogeneity of data and to avoid errors due to occasional vessel deformation, particularly in the least narrowed segments. The absolute area occupied by the lumen was determined by direct planimetry alone in the case of the most narrowed segments (MNP) and segments with the smallest lumen (SL) because calculation of area from the perimeter in these cases would inappropriately normalize luminal irregularities likely to be present in life. On the other hand, in the segments with the largest lumen (LL) and those least narrowed by plaque (LNP), the areas of the lumen were computed both by direct measurement and by calculation from the perimeter to minimize the error due to occasional deformation of these thin-walled segments. It was believed that this method provides for the most accurate measurements. The percent cross-sectional area narrowing by plaque was calculated as (area bounded by the internal elastic lamina minus luminal area) x 100/area bounded by the internal elastic lamina. Histomorphometric measurements were performed using a CUE-2 Image analyzer (Galai Production Ltd) in association with an Olympus BH-2 microprojection system described previously. '5 Statistical Analysis Data are reported as the number of femoral arteries in each experimental group and expressed as mean+SD. Absolute areas are presented as square micrometersxlO3. The angiographic and histopathological differences between treatment groups at a given time point or between the two time points of any one treatment were analyzed using one-way ANOVA followed by an unpaired Student's t test to evaluate two-tailed levels of significance. Rabbits from study A (see "Methods," paragraph 1) were analyzed separately from study B. The two interventional groups of study A (balloon A and balloon+laser) were combined for this analysis. Paired t tests were used for intragroup comparisons.
Pc.05 was considered significant. The STATVIEW512+ statistical package (Brain Power, Inc) was used for these calculations.
Results
Detailed accounts of the nature and extent of the arterial injury at 2 hours and 28 days after balloon angioplasty in this model have been reported previously.7-10 Histological evidence of plaque tear was found in all 16 arteries excised 2 hours after balloon angioplasty and in 47 of 51 excised after 28 days. The plaque tear was into the media or adventitia in all 16 interventional arteries at 2 hours and in 46 of the 47 arteries with plaque tear excised at 28 days. The mean percentage of the perimeter of the internal elastic lamina that was disrupted 2 hours after balloon angioplasty was significantly greater than that of control arteries that were subjected to the same atherogenic regimen (endothelial cell injury followed by cholesterol feeding) but did not have angioplasty (46±23% versus 11+9%, P=.008).
Luminal Diameter by Angiography
The mean percent reduction in luminal diameter caused by endothelial injury and cholesterol feeding (compared with adjacent normal segments) was improved significantly by balloon angioplasty (with or without laser) as observed by angiography at 2 hours (Table 1) .78 This initial gain was followed by significant subsequent reduction in luminal diameter at 28 days that was attenuated significantly in the animals treated with antistasin (mean percent diameter reduction from 2 hours to 28 days after balloon angioplasty [balloon B], 28±19% versus balloon+antistasin, 10+15%; P=.006 by one-way ANOVA) ( Table 1) .
Luminal Area by Histomorphometry
The segment most narrowed by plaque (MNP) was also the one with the smallest lumen (SL) in 65 (81%) of the 80 vessels in this study. (The remaining 16 arteries of the 48 rabbits were totally occluded by atherosclerotic plaque before angioplasty and were not included 
38±11%
17±14% 27±15% *Angioplasty was performed at the site most narrowed by the atherogenic regimen. Each number represents the mean percent (±SD) reduction in luminal diameter at the site of angioplasty from that of the proximal nonangioplastied segment. Balloon only (A) and Balloon+laser are arteries from study A.7 Balloon only (B) and Balloon+antistasin are arteries from study B8 (see "Methods"). Numbers in parentheses are numbers of arteries. Note: The angiographic data for the groups Balloon (B) and Balloon+antistasin include one additional animal not suitable for histomorphometry.
(LNP) was also the one with the largest lumen (LL) in 51 (64%) of the 80 vessels.
The mean absolute luminal cross-sectional area of MNP and SL segments at sites of balloon angioplasty (balloon A plus balloon+laser) was significantly smaller 28 days after the procedure than at 2 hours (MNP: 28 days, 638±327x103,2 versus 2 hours, 1406±1006, P=.003; SL: 28 days, 587±219 versus 2 hours, 964±342, P=.0004), and smaller at 28 days than corresponding segments of nontreated control vessels (MNP, 638 +327 versus 899+195, P=.049; SL, 587±219 versus 861±178, P=.01). Likewise, the absolute luminal cross-sectional area of MNP and SL segments of arteries excised 28 days after balloon angioplasty (balloon B) was smaller than corresponding arterial segments of animals treated with antistasin (MNP, 676+340x 103,u2 versus 924±389, P=.07; SL, 676±340 versus 926±387, P=.06).
The ratio of the mean absolute luminal area of the most to the least narrowed segments (MNP/LNP) of vessels that had balloon angioplasty, with or without laser (balloon A plus balloon+laser), was significantly lower at 28 days than at 2 hours, indicating a significant reduction of luminal area at 28 days ( Table 2 ). However, the ratio of MNP/LNP in control vessels that did not have angioplasty was somewhat higher at 28 days than at 2 hours (Table 2) , and the ratio of the mean absolute luminal area at 28 days of MNP to LNP of angioplastied arteries of animals treated with antistasin was similar to arteries excised 28 days after balloon angioplasty only (balloon B) ( Table 2) .
Comparisons of ratios of absolute luminal areas of SL/LL between the various groups showed similar trends to those of MNP/LNP ( Table 2) .
Cross-sectional Area Narrowing by Plaque
Histomorphometric analysis confirmed that the mean percent luminal cross-sectional area narrowing by atherosclerotic plaque at sites of balloon angioplasty (balloon A plus balloon+laser) was significantly greater 28 days after angioplasty than at 2 hours (MNP, 61±13% versus 32+20%, P=.0001; SL, 61±13% versus 26±24%, P=.0001) or than the 28-day, nonangioplastied control vessels (MNP, 43±13%, P=.006; SL, 41-+ 13%, P=.004) in these studies.) The segment least narrowed by plaque (Table j) (Fig 2) . Each number represents the ratio (±SD) of the absolute luminal cross-sectional area of segments most narrowed by plaque (MNP) to those least narrowed by plaque (LNP) and those with the smallest luminal area (SL) to those with the largest luminal area (LL) 2 hours after and 28 days after balloon angioplasty with or without laser, with or without antistasin, and in nonangioplastied controls. Balloon (A) indicates balloon angioplasty after the atherogenic regimen and death 2 hours or 28 days later; Balloon (B), additional arteries subjected to same procedure as (A) but excised at 28 days as angioplastied controls for animals treated with antistasin; None, arteries with the atherogenic regimen but without angioplasty. Numbers in parentheses are the numbers of arteries in the 2-hour or 28-day groups. P, 2 hours vs 28 days; P1, Balloon±laser vs None; P2, Balloon (B) vs Balloon+antistasin. All P values were derived from one-way ANOVA.
The mean percent luminal cross-sectional area narrowing by plaque of segments of arteries excised 28 days after balloon angioplasty only (balloon B) also was significantly greater than corresponding arterial segments of animals treated with antistasin (MNP [=SL]: 64±16% versus 44±22%, P=.O1). The degree of luminal cross-sectional area narrowing by plaque was significantly greater at sites of angioplasty (SL or MNP) (all treatment groups) than adjacent segments having the largest lumen or least narrowed by plaque (LL or LNP) ( Table 3 ).
These histomorphometric findings are supported by a similar trend in luminal diameter reduction at 28 days seen by angiography (Table 1 ).
In summary, the angiographic and histomorphometric data presented above demonstrate that angioplasty of atherosclerotic arteries in this model system is associated with a reduction in absolute luminal area after 28 days and an increase in luminal cross-sectional area narrowing by plaque relative to adjacent nonangioplastied segments, to corresponding vessels not subjected to angioplasty, and to angioplastied segments of animals treated with antistasin.
Vessel Size by Histomorphometry
An artery-by-artery analysis ( Table 4) shows that at 28 days, the overall vessel size (absolute area bounded .0001
Each number represents the mean percent (±SD) luminal cross-sectional area narrowing by plaque for each of the four segments after balloon angioplasty only (A or B), combined balloon and laser, no angioplasty, or angioplasty in animals treated with antistasin. Numbers in parentheses are numbers of arteries at 2 hours or 28 days. LL indicates largest lumen; LNP, least narrowed by plaque; MNP, most narrowed by plaque; SL, smallest lumen; P, 2 hours vs 28 days (by one-way ANOVA); P1, 2-h MNP vs 2-h LNP or 2-h SL vs 2-h LL (by paired t tests); P2, 28-d MNP vs 28-d LNP or 28-d SL vs 28-d LL (by paired t tests). For explanations of Balloon (A) and Balloon (B) see legend of Table 2 . by the EEL) of segments after balloon angioplasty with or without laser, and balloon angioplasty with or without administration of antistasin, was equal in the majority of cases to the overall vessel size of nonangioplas- Subtotal' (51) 5 33 (65%) 13 8 31 (61%) 12 Subtotal2 (51) 4 43 (84%) 4 6 41 (80%) 4 Each is the number (percent) of arteries in which the vessel size (area bounded by the external elastic lamina) of the MNP or SL segment is equal to, less than, or greater than the adjacent LNP or LL segment within 1 SD. Numbers in parentheses are numbers of arteries in each group. LL indicates segment with the largest lumen; LNP, segment with lumen least narrowed by plaque; MNP, segment with lumen most narrowed by plaque;
Subtotal', all 28-day arteries except for "None" (within 1 SD); Subtotal2, all 28-day arteries except for "None" (within 2 SD). Of the sites of angioplasty that were not equal in overall vessel size to adjacent segments, some were smaller (MNP<LNP, 5 [10%]; SL<LL, 8 [16%]), but most were larger (MNP>LNP, 13 [25%]; SL>LL, 12 [24%]). Thus, the vessel size of angioplastied segments at 28 days was either the same or larger than adjacent nonangioplastied segments of the same vessel in 46 (90%) of MNP versus LNP segments or in 43 (84%) of SL versus LL segments.
The mean absolute total vessel size of MNP and SL segments 28 days after angioplasty (balloon A and balloon+laser) was similar to those of arteries analyzed just 2 hours after angioplasty (MNP: 28 days, 2582±1088 x 10 ,2versus 2 hours, 3216+2209, P=.28; SL: 28 days, 2410±819 versus 2 hours, 2046±927, P=.23) and not significantly different from corresponding segments of nonangioplastied control arteries (MNP, 2069±450, P=.33; SL, 1857±281, P=.12). The absolute arterial size of segments excised 28 days after balloon angioplasty only (balloon B) was also similar to corresponding segments of antistasin-treated animals (MNP: balloon only, 2214 ±418 x 103,u2 versus balloon+antistasin, 2189±585, P=.90; SL: balloon only, 2214±418 versus balloon+ antistasin, 2176±593, P=.84).
The mean absolute EEL area of segments with the smallest lumen of all arteries excised 28 days after balloon angioplasty (with or without laser or antistasin) was similar to adjacent segments of the same arteries with the largest lumens (SL: 2273±649x 103p2 versus LL: 2282±1008, P=.96). Furthermore, the arterial size of the MNP segments was somewhat greater than adjacent LNP segments (MNP: 2319±776x 103g, versus LNP, 1892±789, P=.01). The ratios of the area bounded by the EEL of MNP/LNP and SL/LL of arteries excised 28 days after balloon angioplasty (balloon A and balloon+laser) were also not significantly different from those excised after 2 hours and not different from the 28-day control arteries (Table 5 ).
Discussion
From this study, we conclude that luminal crosssectional area narrowing by plaque was the principal morphological feature associated with restenosis after angioplasty in this model. By contrast, the overall arterial size (area bounded by the EEL) at the site of restenosis was not significantly different from either adjacent nonangioplastied segments, from corresponding segments of nonangioplastied control arteries, or Each number represents the ratio (±SD) of the absolute area bounded by the external elastic lamina of segments whose lumen is most narrowed by plaque (MNP) to those least narrowed by plaque (LNP) and those with the smallest luminal area (SL) to those with the largest luminal area (LL) 2 hours and 28 days after balloon angioplasty with or without laser, with or without antistasin, and in nonangioplastied controls. Numbers in parentheses are numbers of arteries in the 2-hour or 28-day groups. P, 2 hours vs 28 days; P1, balloon±laser vs none; P2, balloon (B) vs balloon +antistasin. All P values were derived from one-way ANOVA. For explanations of Balloon (A), Balloon (B), and None, see legend of Table 2. from angioplastied segments of animals effectively treated with the factor Xa inhibitor antistasin to attenuate plaque growth. Consequently, geometric remodeling (decrease in arterial size) does not appear to account for the late luminal narrowing after balloon angioplasty with or without prior laser angioplasty in this model. Arterial size was assessed by mean absolute values and artery-by-artery analysis, which is essential to determine the number of individual cases in which the arterial size at the site of angioplasty remained the same or was smaller or larger than adjacent nonangioplastied segments.
The pathophysiological mechanism of restenosis has been considered to include migration and proliferation of smooth muscle cells, elaboration by these cells of abundant extracellular matrix (fibrous tissue), and a resultant progressive decrease in luminal size. A recent serial, quantitative intravascular ultrasound study of patients with clinical restenosis, in which motorized transducer pullback was used after transcatheter therapy, has suggested that the predominant mechanism of reduction in luminal area after balloon angioplasty, atherectomy, or excimer laser angioplasty is geometric remodeling.5 Late decrease in vessel size rather than tissue growth was reported to account for 65% of the late luminal loss and was independent of the therapeutic device used.5"16
The impact of arterial remodeling after angioplasty also has been addressed in a number of animal models. The preliminary report of Lafont et al,6 using the atherosclerotic rabbit model, suggested that the restenotic process is mediated by both chronic constriction and proliferation. A similar conclusion was reached by Katuka et al,17 using a similar rabbit model. However, the relative contribution of neointimal formation and arterial remodeling was not reported. Conflicting results have been reported in studies of oversized balloon dilation in pig coronary arteries. Brott et al18 observed a similar degree of neointimal response in pigs and dogs but reported a greater degree of remodeling in the pig. By contrast, Waksman et al,19 using a similar model in pigs, concluded that early restenosis is due to neointimal formation rather than vascular remodeling. In the present study, individual as well as mean values are presented for sites of angioplasty and adjacent, nonangioplastied segments of arteries subjected to different interventional strategies including balloon only, laser plus balloon, no balloon, and balloon with antistasin. A decrease in overall vessel size was present only in a small minority (10% to 16%) of restenotic vessels and therefore was not the predominant pathogenetic mechanism for the reduction in luminal area after angioplasty in this model.
Recently, O'Brien et a14 evaluated the extent of smooth muscle cell proliferation in human coronary atherectomy specimens from primary atherosclerotic and restenotic lesions using PCNA. Their results showed that cell proliferation was infrequent and occurred at low levels in both primary and restenotic lesions. They concluded "either that the biology of restenosis is very different in animals compared with human atherosclerotic vessels or that restenosis is due to processes other than the intimal hyperplasia that is usually studied in animal models." However, these findings do not contradict those of the present study. A number of studies have suggested that the principal wave of smooth muscle cell proliferation occurs in the first 2 to 3 weeks after balloon angioplasty,20'21 whereas few of the restenotic specimens studied by O'Brien et al were harvested during that time period. Analysis of atherosclerotic coronary arteries of patients with fatal coronary artery disease shows that the percentage of plaque occupied by cellular versus acellular fibrous tissue decreases with increasing degrees of luminal narrowing (plaque size).22-24 Moreover, the findings concerning the proliferative response of these cells do not address the factors responsible for expression and elaboration by these cells of abundant extracellular matrix at these sites. 25 Animal studies that describe neointimal growth, particularly those involving balloon withdrawal injury or angioplasty of normal arteries, have been criticized as to their applicability to the natural history of restenosis in humans. The present study uses a second-injury model in which focal atherosclerosis was induced by a combination of endothelial injury and a hypercholesterolemic diet. Studies by our group using this model have shown that fibrocellular tissue is, by far, the predominant tissue component of the plaques at sites of balloon angioplasty, and foam cells occupy, on the average, approximately 10% of the plaque.79"15 The principal histological component of the atherosclerotic plaque at sites of balloon angioplasty in humans is also fibrous tissue, with a variable degree of calcific deposits and a small amount of lipid.26 However, little is known about the structural composition or pathogenesis of the restenotic plaque early after coronary interventions in humans. ' Thus, although we cannot exclude the possibility that a reduction in vessel size may be a factor after more prolonged survival times, geometric remodeling is not the principal pathogenetic process in restenosis 1 month after balloon angioplasty in this model. Efforts should continue to focus on factors responsible for the elaboration of the abundant fibrous tissue matrix that forms the bulk of both primary and restenotic lesions in experimental animals and humans.
